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Abstract 
Adult obesity has become a significant problem in the United States.  To reduce health 
consequences and the rising cost of obesity, evidence-based guidelines to identify and treat 
obesity are available to primary care providers (PCPs).  Despite literature supporting favorable 
outcomes by PCPs who address obesity at a patient's visit, studies indicate obesity counseling is 
occurring infrequently, particularly in military primary care settings. 
 Guided by the Diffusion of Innovations Theory, this research utilization project evaluated 
whether there is an implementation gap between use of the Department of Veterans Affairs (VA) 
and Department of Defense (DoD) Clinical Practice Guideline for Screening and Management of 
Overweight and Obesity and military primary care providers’ provision of care for adult obese 
individuals.  A retrospective review of electronic medical records was conducted at an Air Force 
military treatment facility and continued until 50 records were identified that met inclusion 
criteria (i.e., TRICARE beneficiaries age 19 and older with a body mass index (BMI) of 30 
kg/m2 or greater). 
 The rate of identification of adult obesity was 36%.  Only 36% of individuals were 
offered diet and exercise counsel.  Sixteen percent were offered behavioral counsel and 12% 
received a one-month follow-up appointment.  No individuals eligible to receive pharmacologic 
and bariatric surgical treatment were offered these interventions.  The overall composite score 
for obesity treatment was 0.22, indicating identification and treatment of obesity occurred an 
average of 22% of the time.  Results of this research utilization project are consistent with other 
studies, suggesting the need to determine barriers and implement interventions that can assist PCPs 
in translating evidence to practice to reduce rates of adult obesity in the primary care setting.    
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Chapter I 
Introduction 
 Clinically, body weight status (i.e., underweight, overweight, obesity) is characterized by 
the BMI—the ratio of an individual’s weight (in kilograms) to the square of the individual’s height 
(in meters).  For adults, obesity is defined in terms of a BMI equal to or greater than 30 kg/m2 
(Centers for Disease Control and Prevention [CDC], 2012a).  Since the 1990s, when the prevalence 
of adult obesity in the United States (U.S.) averaged 10%–14%, this rate more than tripled 
(Behavioral Risk Factor Surveillance System [BRFSS], 1990).  In 1998, the prevalence was 15%–
19%; by 2007, 20%–24%; and by 2013, 25%–35% (BRFSS, 2013).  A study of a military adult 
active (AD) population found that from 2009 to 2012 the prevalence of obesity was 30.5%, which 
was lower than the general population; however, for the non-active duty population, a prevalence 
of 35.1% was comparable to the general population (Eilerman et al., 2014).  Today, the prevalence 
of obesity in the U.S. is over 36%, while the obesity rate for adults age 40–59 is as high as 40.2% 
(Ogden, Carroll, Fryar, & Flegal, 2015).   
Causes of Obesity 
There are many factors influencing obesity, including physiological, psychological, 
sociological, and environmental associations.  In a study conducted by Owen-Smith, Donovan, and 
Coast (2014), morbidly obese individuals reported several reasons for weight gain.  The 
researchers grouped these into four broad categories:  (a) personal responsibility and “morality” of 
health (e.g., individual’s attitude that mitigates personal accountability); (b) role of family structure 
and importance of gender; (c) role of emotional distress and its impact on the body; and (d) the 
vicious cycle and downward spirals that compound health conditions.  Respondents felt there were 
numerous psychosocial patterns, family history, and genetics that contributed to obesity.  
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Individuals reported that increased weight adversely affected physical and social aspects of daily 
living that led to despair.  Study participants felt it was a “vicious circle” (p. 1217) that was 
difficult to stop. 
Physiological factors.  Physiologically, obesity results from overnutrition.  An imbalance 
between caloric intake and energy expenditure leads to increased adipose tissue storage (Skolnik & 
Ryan, 2014).  Adipose tissue and stomach regulators release chemical messengers that stimulate 
the brain, creating an intricate balance between starvation and satiety that regulates body weight 
(Chugh & Sharma, 2012; Skolnik & Ryan, 2014).  When regulation becomes imbalanced, adipose 
tissue secretes harmful inflammatory markers that lead to metabolic dysfunction of glucose and 
cholesterol (Tchernof & Després, 2013).  Research also indicates that through epigenetic 
mechanisms, maternal dietary patterns increase the susceptibility to obesity that affect offspring by 
inducing alterations through genetic expression (Martinez, Milagro, Claycombe, & Schalinske, 
2014). 
 Psychological, sociological, and environmental factors.  A range of diverse psychosocial 
and environmental factors increase the risk of obesity.  Childhood socialization patterns and family 
roles, work patterns, and diet failures contribute to obesity (Owen-Smith et al., 2014).  Insufficient 
sleep patterns (Chaput, 2014) and emotional stress can potentiate the effects of obesity (Chao, 
Grilo, White, & Sinha, 2015; Turk et al., 2012).  Individuals report that weight adversely affects 
relationships and contributes to fear of discrimination, low self-esteem, and self-loathing (Owen-
Smith et al., 2014).  Business and manufacturing have also impacted obesity rates.  Portion sizes 
served in U.S. restaurants have increased two to three times over the past two decades (National 
Heart, Lung, and Blood Institute, 2013).  Karnani, McFerran, and Mukhopadhyay (2014) coined 
the term "leanwashing" (p. 5) to describe how the food industry deceives the public into believing 
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that the industry is helping to find ways to fight obesity—when, in fact, this industry contributes to 
the prevalence of obesity in the general population through marketing of unhealthy processed 
foods. 
Consequences of Obesity 
The body's inflammatory response to obesity contributes to several comorbid conditions.  
Heart disease, stroke, type 2 diabetes (T2DM), hypertension (HTN), dyslipidemia, metabolic 
syndrome, and obstructive sleep apnea (OSA) have been associated with obesity (Cawley & 
Meyerhoefer, 2012; Ding et al., 2015; Drager, Togeiro, Polotsky, & Lorenzi-Filho, 2013; Owen-
Smith et al., 2014).  Obesity also contributes to osteoarthritis and some types of cancer (Arnold et 
al., 2016; Hootman, Helmick, & Hannan, 2011, April 29).   
Estimates of obesity-related health care costs vary significantly.  For example, An (2015) 
estimated the health care cost of an individual with obesity in the U.S. is $1,809 higher than non-
obese individuals; in contrast, Cawley and Meyerhoefer (2012) estimate the cost to be $2,741.  A 
2012 estimate of obesity related costs was $147 billion (CDC, 2015).  The military health system 
spends more than $1.1 billion annually on individuals with overweight and obesity-related 
conditions, losing an estimated $1.1 million annually due to absenteeism and an additional $2.6 
million annually due to presenteeism, where workers are less productive on the job due to health 
issues (Hruby et al., 2015).  A cost of more than $1 billion annually is reported by the Department 
of Veterans Affairs (VA) for obesity-related issues (Tanofsky-Kraff et al., 2013). 
Hruby et al. (2015) evaluated trends for individuals entering the Army.  Administrative 
costs increase for recruits who cannot meet physical stature and fitness requirements, resulting in 
premature separation of the individual from service.  It is estimated 27% of potential recruits (9 
million young adults) are not eligible to enlist for military service because they do not meet weight 
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standards (Tanofsky-Kraff et al., 2013).  This negatively influences military readiness and national 
security.  
Benefits of Weight Loss 
Weight loss has clear benefits.  With each kilogram of weight gained, the risk of T2DM 
increases 4.5% to 9% across one to two decades (Rueda-Clausen, Ogunleye, & Sharma, 2015).  
Mitigation of risk for T2DM occurs with as little as 5% to 10% weight loss, which is shown to 
improve blood pressure, cholesterol, and glucose levels (Kushner & Sur, 2014).  Weight loss has 
also been associated with reduced osteoarthritis, reduced urinary and fecal incontinence, and, in 
women, reduction in the severity of polycystic ovarian syndrome that can reduce the risk of 
infertility (Rueda-Clausen et al., 2015). 
 Given the negative influence that obesity has on health and quality of life, several obesity 
guidelines recommend comprehensive, high-intensive, multicomponent lifestyle interventions to 
reduce obesity and its consequences (VA/Department of Defense [DoD], 2014; Jensen et al., 2013; 
Moyer, 2012).  In 2010, the U.S. Department of Health and Human Services (USDHHS) 
established Healthy People 2020 goals for healthy eating and maintaining a normal weight 
(USDHHS, 2010), and in 2011 the Centers for Medicare & Medicaid Services (CMS) approved up 
to 14 visits over 6 months for obesity counseling (CMS, 2011), in an effort to minimize obesity's 
negative consequences. 
Problem Statement 
Although clinical guidelines for the management of obesity in the primary care setting 
exist, obesity rates continue to rise.  Studies show counseling by PCPs at a clinic visit reduces 
the rate of obesity (Kanaya, 2012; Sprau, Tindall, Lovegrove, Watowicz, & Eneli, 2015; 
Wadden, Butryn, Hong, & Tsai, 2014).  Kraschnewski et al. (2013) reported that there has been a 
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decline in weight-related counseling in the primary care setting.  Rates evaluated from 1995 to 
1996 and 2007 to 2008 found a decrease in counseling rates from 7.8% to 6.2%.  A survey of 1,740 
PCPs regarding weight screening and treatment practices noted greater than 80% of PCPs had 
available diet, exercise, and weight control resources; however, only 45% billed for counseling or 
treatment services and just 26% reported on obesity assessment or routine counseling and tracking 
of weight control progress (Klabunde et al., 2014).  In a systematic review of 12 clinical trials 
conducted from 2005 to 2013, no studies utilized the recommended comprehensive lifestyle 
interventions of 14 sessions over a six-month timeframe (Wadden et al., 2014). 
Lack of knowledge or disagreement with the guidelines, attitude or self-efficacy, 
anticipated outcomes, apathy, and external barriers were cited as reasons PCPs do not initiate 
obesity counseling (Sadeghi-Bazargani, Tabrizi, & Azami-Aghdash, 2014).  Other barriers that 
persist are lack of time and consistency in care, individual receptivity, compliance with change, 
and lack of organizational support or constraints (Abruzzino & Marra, 2015; Monsen et al., 
2014; Sadeghi-Bazargani et al., 2014; Sinfield, Baker, Pollard, & Tang, 2013).  Collectively, 
these barriers contribute to an underutilized resource for the identification and treatment of 
obesity in the primary care setting. 
Purpose Statement  
The PCP plays a crucial role in reducing the rate of obesity for adults in primary care.  
Evidence-based recommendations are available to guide PCPs in the management of adult 
obesity.  The purpose of this project is to examine electronic medical records (EMRs) of adults 
who meet criteria for obesity and compare documented treatment with treatment recommended 
according to the evidence-based VA/DoD obesity screening and management guideline. 
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Chapter 2 
Literature Review 
The purpose of this literature review is to define adult obesity and to compare and 
contrast current evidence-based obesity guidelines.  This review will explore current practices 
for the identification and treatment of obesity by PCPs.  Additionally, this review will investigate 
gaps and interventions available to improve translating evidence-based guidance into primary 
care settings. 
Key terms and phrases used for the literature search were:  obesity, adult obesity, 
definition of obesity, impact of obesity, primary care and obesity, management of obesity in 
primary care, obesity clinical practice guidelines, obesity treatment, evidence-based practice 
(EBP), barriers to use of clinical practice guidelines, interventions and clinical practice 
guidelines, and Diffusion of Innovations Theory.  Databases searched were Annual Reviews, 
Business Source Complete, Cochrane Reviews, CINAHL, PsychInfo, PubMed, and 
ScienceDirect.  Articles published in English and from the year 2011 were included.  Articles 
dated earlier than 2011 were included only if they contained relevant historical information that 
support this research utilization project. 
Defining Adult Obesity 
Obesity has been present throughout history, uncovered even in artifacts dating back to 
the Stone Age.  Through ancient times, obesity occurred in the higher class in Egypt.  The first 
literature written about obesity appeared in the 18th century when Adolphe Quételet, a Belgium 
astronomer and mathematician, devised an equation to measure a person’s height relative to their 
body weight called the Quételet Index, better known as the BMI (Williams & Frühbeck, 2009).   
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 Medically defined, adult obesity is the accumulation of excess body fat in individuals 
aged 20 years and older (CDC, 2012b).  However, quantifying obesity has been more 
challenging.  The first measurements were established by the Metropolitan Life Insurance 
Company, which developed actuarial tables based on gender and weight-for-height using data 
from the Build and Blood Pressure Study published in 1959 (Simopoulos, 1986).   
By the 1960s, a national survey utilized height and weight measurements of examined 
and non-examined individuals (USDHHS, 1974).  This later became the National Health and 
Nutrition Exam Survey in the 1970s after a dietary component was included in the survey (CDC, 
2014).  Currently, BMI is used nationally and internationally to define obesity (CDC, 2016; 
World Health Organization [WHO], 2016).  Obesity is categorized as Grade I obesity with a 
BMI >30 – 34.9 kg/m2, Grade II obesity with a BMI >35 – 39.9 kg/m2, and Grade III obesity, 
also known as morbid obesity, with a BMI >40 kg/m2.   
Other common anthropometric measures used to quantify obesity are waist circumference 
(WC), waist-to-hip ratio (WHR), waist-to-stature ratio (WSR), and percentage of body fat 
(Rueda-Clausen et al., 2015).  The military takes measurements of the neck and abdomen to 
calculate percent of body fat for individuals who fail the weight or abdominal circumference 
portion of the physical fitness test (Secretary of the Air Force [AF], 2015).  Mohammadifared et 
al. (2013) found that although BMI is a better predictor of T2DM, HTN, and dysplipidemia in 
men, WC is a better indicator of diabetes and hypertension in women.  In an Expert Consultation 
Report, the WHO recommends use of either WC or WHR in conjunction with BMI (WHO, 
2008), as these measures are viewed as more accurate indicators of cardiovascular (CV) disease 
risk (Nazare et al., 2015; Xu et al., 2015).   
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 Newer technologies available to measure body fat are magnetic resonance imaging 
(MRI), computed tomography (CT), ultrasonography, and bone densitometry (DEXA), as well as 
air displacement plethysmography, known as the BodPod, and hydrodensitometry, which is a 
water weighing technique (Müller et al., 2013; Rueda-Clausen et al., 2015).  These technologies 
are accurate but incur greater cost and time to obtain measurements, while the bioelectrical 
impedance can result in fluctuations due to hydration status (Rueda-Clausen et al., 2015).  See 
Appendix A for advantages and disadvantages of current methods to measure obesity. 
Some disadvantages when using BMI relate to an over or underestimate of body fat 
percentage (De Schutter, Lavie, Arce, Menendez, & Milani, 2013).  Further, BMI does not 
discern between lean versus fat mass, resulting in inaccurate body fat analysis (Lambert et al., 
2012).  In non-Europeans, particularly Asians, CV risk is higher despite a normal BMI.  
Consideration to lower the BMI threshold to diagnose obesity at >25 kg/m2 has been 
recommended for this population (WHO, 2000).  Despite these known limitations, BMI remains 
a widely accepted anthropometric measure for its ease of use and cost-effectiveness in the 
primary care setting.  Until an uncomplicated technology becomes available, use of BMI remains 
a key clinical tool to assess obesity. 
Recommended Adult Obesity Guidelines 
Four current obesity guidelines for clinical practice are available.  These include:  (a) the 
2015 Endocrine Society guideline for the pharmacological management of obesity (Apovian et al., 
2015); (b) the 2014 VA/DoD guideline to screen and manage adult overweight and obese 
individuals; (c) the 2013 American Heart Association (AHA) Task Force, American College of 
Cardiology (ACC), and The Obesity Society (TOS) guideline for adult overweight and obesity 
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management (Jensen et al., 2013); and (d) the 2012 United States Preventive Task Force (USPTF) 
recommendation statement on the screening and management of adult obesity (Moyer, 2012).   
The Appraisal of Guidelines for Research and Evaluation II (AGREE II) Instrument is a 
23-item survey to assess quality, methodological strategy, and nature of the information reported in 
the guidelines (Brouwers et al., 2010).  The six domains for guideline evaluation are:  (a) scope and 
purpose; (b) stakeholder involvement; (c) rigor of development; (d) clarity of presentation; (e) 
applicability; and (f) editorial independence.  Evaluation results are available in Appendix B.  
 Both VA/DoD (2014) and AHA/ACC/TOS (Jensen et al., 2013) guidelines scored high in 
scope and purpose, rigor of development, and clarity of presentation domains.  However, the 
VA/DoD (2014) guideline provided the most comprehensive recommendations.  Treatment 
recommendations from VA/DoD include diet, exercise, behavioral modification, and adjunct 
therapies for pharmacological and surgical intervention.  The AHA/ACC/TOS guideline does not 
include pharmacologic therapy, but when coupled with the Endocrine Society's 
recommendations (Apovian et al., 2015), the AHA/ACC/TOS guideline is equally 
comprehensive as the VA/DoD guidance.  Recommendations in the USPTF guideline (Moyer, 
2012) mirror VA/DoD and AHA/ACC/TOS on use of comprehensive lifestyle intervention 
(CLI).  No guidelines addressed individual or public involvement, although the VA/DoD and 
Endocrine Society recommend use of shared decision-making when treating individuals with 
obesity.  See Appendix C for an overview of the obesity guidelines. 
Identification of Adult Obesity in Primary Care 
Obesity is identified in the presence of a BMI >30 kg/m2.  Both VA/DoD (2014) and 
AHA/ACC/TOS (Jensen et al., 2013) guidelines recommend initiation of CLI and offering 
pharmacologic intervention for a BMI >27 kg/m2 if an individual has comorbid conditions.  The 
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guideline by AHA/ACC/TOS advocates for use of WC as an additional assessment tool, though 
there is no cut-point recommendation for this measure.  Skolnik and Ryan (2014) report that a 
WC greater than 40 inches for males and greater than 35 inches for females has been associated 
with increased risk of CV disease.   
McKinney (2013) discusses metabolic syndrome as a comorbid condition even when an 
individual does not meet BMI criteria for obesity.  Identification of this syndrome can inform the 
PCP to intervene at earlier stages to reduce future CV risk.  In addition to a WC cut-point of 
greater than 40 inches in males and greater than 35 inches in females, other indicators are as 
follows:  (a) a triglyceride level above 150 mg/dl; (b) a high density lipoprotein cholesterol level 
less than 40 in males and less than 50 in females; (c) an elevated blood pressure above 130/85 or 
receiving treatment for HTN; and (d) an elevated fasting glucose above 100 or being treated for 
elevated glucose.  Meeting three of the five criteria is diagnostic of metabolic syndrome. 
Treatment of Adult Obesity in Primary Care  
The AHA/ACC/TOS (Jensen et al., 2013), VA/DoD (2014), and USPTF (Moyer, 2012) 
guidelines recommend lifestyle interventions for the treatment of obesity.  Both AHA/ACC/TOS 
and VA/DoD guidelines describe this as comprehensive, while USPTF describes the intervention 
as intensive and multicomponent.  Modalities under lifestyle interventions are 
nonpharmacologic, including diet, exercise, and behavioral counseling.  Variations among the 
guideline treatment recommendations exist; some initiate interventions at different cut-points and 
some interventions vary in degree of intensity.   
The Endocrine Society supports the use of diet, exercise, and behavioral counseling but 
does not use the terms comprehensive or multicomponent (Apovian et al., 2015).  In the presence 
of comorbid conditions, a cut-point BMI of >27 kg/m2 is used to establish when CLI and 
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pharmacologic management should be started.  A BMI of >40 kg/m2 or >35 kg/m2 with 
comorbid conditions is a cut-point for considering bariatric surgical intervention (Apovian et al., 
2015; Jensen et al., 2013; VA/DoD, 2014). 
 Dietary and physical activity.  The importance of diet and physical activity is the 
hallmark for obesity treatment.  Prescribing a particular diet or exercise regimen can be 
perplexing for the PCP due to limited time or level of expertise (Plourde & Prud'homme, 2012).  
Fortunately, research indicates that diet is not dependent on a specific regimen to improve weight 
loss outcomes or reduce CV risks.  Rather, it is calorie restriction and adherence to the dietary 
modification that equate to success (Johnston et al., 2014; Rees et al., 2013).  This simple 
recommendation makes it easier for a PCP to provide dietary counsel.   
 A diet and physical activity plan that decreases caloric intake by 500 to 1,000 kilocalories 
(kcals)/day can reduce weight at a rate of one-half to two pounds weekly.  This diet and exercise 
intervention can result “in a 5-10% reduction in body weight over [six] months” (VA/DoD, 
2014, p. 29).  The AHA/ACC/TOS guideline recommends a caloric deficit of 500 to 750 
kcals/day (Jensen et al., 2013).  Very low calorie diets consist of a daily caloric intake of >450 
kcals but <800 kcals (Mullins, Hallam, & Broom, 2011).  The VA/DoD (2014) guidance 
recommends offering this option only for 12 to 16 weeks under medical supervision.  The 
AHA/ACC/TOS (Jensen et al., 2013) guideline did not find adequate evidence to recommend 
this as a dietary treatment.  Other dietary cautions are to avoid reduced caloric intake for 
individuals who are pregnant or lactating or who have a history of anorexia nervosa, bulimia, or 
unstable illness such as cancer or recent CV events (Kushner & Sur, 2014). 
 The American College of Sports Medicine (ACSM) recommends 150 to 250 minutes of 
physical activity weekly to assist in weight loss (ACSM, 2011).  Interestingly, physical activity 
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alone has not resulted in significant weight loss (Kushner & Sur, 2014; Plourde & Prud’homme, 
2012; Thomas, Kyle, & Stanford, 2015).  Weight loss through exercise requires very high 
intensity activity.  As the body loses weight, the amount of energy expended decreases.  At a 
10% loss in body weight, there will be a 15% reduction in energy expenditure (McKinney, 
2013).  Therefore, the additive effect of energy expenditure through exercise improves 
continuation of weight loss (VA/DoD, 2014).   
Notably, physical activity plays a larger role in maintaining weight and improving CV 
risks.  In a study conducted by Dankel, Loenneke, and Loprinzi (2015), independent of 
overweight or obesity status, a decrease in activity increased the risk of all-cause mortality.  
Vigorous activity demonstrates a greater effect upon decreasing respiratory and CV disease risk.  
Any exercise that promotes muscle strength and flexibility enhances bone density and joint 
flexibility (ACSM, 2011). 
Intensive behavioral counsel.  Combining diet and physical activity with behavioral 
modification strengthens both weight loss and weight maintenance for adults with obesity 
(Roqué i Figuls et al., 2013).  The frequency for intensive behavioral treatment of obesity, as 
established by CMS (2011), equates to one face-to-face visit weekly for the first month, then 
every other week for the next five months.  During months 7 through 12, visits are to be face-to-
face monthly, totaling 20 visits per year.  This closely mirrors USPTF’s recommendation 
(Moyer, 2012) for 12 to 26 sessions per year.  VA/DoD (2014) recommends 12 visits yearly, 
while AHA/ACC/TOS recommends a high-intensity frequency of >14 sessions within six 
months (Jensen et al., 2013).   
Although session frequency varies, the Diabetes Prevention Program found progression 
to diabetes was reduced 60% when using intensive behavioral intervention, versus a 31% 
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reduction with usual care (McKinney, 2013; Sussman, Kent, Nelson, & Hayward, 2015).  During 
the Look AHEAD trial, which stands for Action for Health in Diabetes, participants experienced 
a statistically significant amount of weight loss for individuals with Grade III obesity receiving 
intensive therapy, more than individuals with Grade I and II obesity receiving a less intensive 
therapy (Unick et al., 2011).  Further, telephone-delivered counsel is a convenient and cost-
effective approach to the delivery of behavioral services (Wadden et al., 2014).  Utilizing a 
commercial provider such as Weight Watchers was as cost-effective as standard care, leading to 
an average weight reduction of 4.8 – 6.6 kg across six months (Fuller et al., 2013; Jensen et al., 
2013). 
The importance of other behavioral strategies can increase an individual’s success with 
weight loss and management.  Assessing readiness, removing barriers to assist in reaching 
realistic goals, and self-monitoring are a part of intensive treatment regimens that result in 
greater weight loss (Jensen et al., 2013; Moyer, 2012).  To assist individuals who are ambivalent 
about changing behaviors, use of motivational interviewing can improve weight loss efforts 
(Pearson, Irwin, Morrow, Battram, & Melling, 2013; VA/DoD, 2014).  The 5As developed by 
the CMS provides counseling in a stepwise approach to help individuals make behavioral 
changes.  The 5As address assessment and advice of the individual, agreeing to reach goals 
through shared decision-making, assisting in the individual's self-monitoring and goals, and 
arranging follow-up and referrals for obesity treatment (McKinney, 2013; Vallis, Piccinini-
Vallis, Sharma, & Freedhoff, 2013). 
Pharmacologic and surgical intervention.  Adjunctive obesity therapies include 
pharmacological and surgical options.  Pharmacotherapy is considered when nonpharmacologic 
interventions have not improved weight loss and when an individual’s BMI is >30 kg/m2 or >27 
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kg/m2 associated with comorbid conditions (Apovian et al., 2015; Jensen et al., 2013; VA/DoD, 
2014).  A meta-analysis by Johansson, Neovius, and Hemmingsson (2014) demonstrated 
pharmacologic therapy also enhances weight loss maintenance.  The VA/DoD currently 
recommends individuals continue on weight loss medication after reaching their weight loss goal 
to assist with weight maintenance (VA/DoD, 2014).  
Medications available for long-term use are orlistat, phentermine, lorcaserin, liraglutide, 
or combinations of either naltrexone with bupropion or phentermine with topiramate (Apovian et 
al., 2015).  Appendix D outlines these agents, their activity, recommended dosages, and risks and 
benefits.  When selecting medication therapies for obese individuals with comorbid conditions, 
the Endocrine Society also recommends to choose options that have the least weight gain side 
effect and to exercise caution when prescribing stimulants for individuals with a CV history 
(Apovian et al., 2015).  Johansson et al. (2014) did not find benefit for use of nutritional 
supplements.  It is necessary for PCPs to have a baseline knowledge of benefits, risks, and 
alternatives to nutritional supplements to provide effective obesity counsel. 
Bariatric surgery has shown to be an effective option for obesity treatment.  
Consideration is made for individuals with a BMI >40 kg/m2 or those with a BMI >35 
kg/m2 who have comorbidities (Apovian et al., 2015; Jensen et al., 2013; VA/DoD, 2014).  
Although USPTF did not review surgical intervention as an obesity treatment, guideline 
recommendations did support this option (Moyer, 2012).  The most common procedures are 
Roux-en-Y gastric bypass, laparoscopic band, and the gastric sleeve (VA/DoD, 2014).  
Depending on the procedure, a 20% to 35% sustained weight loss across two to three years’ post-
surgery is reported (Ryan, 2014).  Additionally, there is greater reduction of T2DM and 
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metabolic syndrome, and improved quality of life, than with nonsurgical interventions alone 
(McKinney, 2013; Ryan, 2014). 
 Surgical intervention can increase weight loss; however, the individual must understand 
there are inherent risks with this option.  The occurrence of surgical complications, along with 
ulceration, malabsorption of micronutrients following gastric bypass, treatment failure, and 
adverse psychological events have been reported (McKinney, 2013; Jensen et al., 2013; Ryan, 
2014; VA/DoD, 2014).  It is important for PCPs to understand the risks and benefits of surgical 
treatment, as well as the management of surgical candidates post-operatively.  Guidelines for 
post-operative care through The Obesity Society, the American Society for Metabolic & 
Bariatric Surgery, and the American Association of Clinical Endocrinologists are available to 
assist PCPs (Ryan, 2014). 
Needs Assessment 
The prevalence rate of obesity in the AD population is slightly below the civilian 
community, while the non-AD military population is comparable to the civilian sector (Eilerman 
et al., 2014).  Even though evidence-based guidelines exist and it is known that weight loss 
endeavors are more likely to occur when PCPs engage individuals on obesity (Dutton et al., 
2014), the literature indicates this has declined 12% from 2008 to 2013 (Fitzpatrick & Stevens, 
2017).  With rising health care costs from comorbidities associated with obesity, it is critical for 
military PCPs to address this issue at clinic visits.   
 Population identification.  Eilerman et al. (2014) indicates the AD military's prevalence 
rate of obesity was 30.5% from 2009 to 2012.  Smith et al. (2012) found that while overweight 
rates for AD declined from 2002 to 2005, obesity rates rose significantly.  Where 40% of the AD 
military population report a healthy weight, only 33% of military dependents are at a healthy 
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weight (Eilerman et al., 2014).  For purposes of this research utilization project, TRICARE 
beneficiaries 19 years of age and older (i.e., AD, AD dependent, retirees, retiree dependents, and 
TRICARE-for-Life) will be included. 
Identification of the project sponsor/key stakeholders.  Evaluation will be conducted at 
a military treatment facility (MTF) located in Maryland.  Key stakeholders include the 
organization's executive leadership, the AF Diabetes and Obesity Research Working Group, 
Population Health Working Group, PCPs, nursing and technician staff, nutritional and behavioral 
medicine, and TRICARE beneficiaries.  External stakeholders are United Health Care and the 
VA/DoD. 
Organizational assessment/assessment of available resources.  The MTFs provide 
primary care services for TRICARE beneficiaries.  The current model of care is the AF Medical 
Home model.  The medical home is comprised of a grouping of individual provider teams, which 
include one physician and either a physician assistant (PA) or nurse practitioner (NP), or a 
combination of the two.  Enrollment for each PCP in the Family Practice Clinic is 1,250 
TRICARE beneficiaries. 
 The PCPs utilize an EMR, which automatically calculates BMI.  Clinic visits are 15 to 20 
minutes in length.  A PCP’s support team is comprised of administrative, nursing, and medical 
technician staff.  Internal referral services are available for nutritional and behavioral medicine 
services.  These services are offered dependent on availability of nutritional and behavioral 
medicine staff.  No exercise physiologist is available, but all TRICARE beneficiaries possess a 
military identification card that affords access to the base fitness center.  Physical therapy 
services are available, but access is limited for exercise management.  Although PCPs may 
prescribe pharmacologic options, this option is not a covered benefit under TRICARE 
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(TRICARE, 2016).  A nonformulary request can be placed by the PCP to assist individuals with 
coverage of their pharmacologic treatment but is dependent on pharmacy approval.  Bariatric 
surgical options are covered for individuals whose BMI is > 35 kg/m2 with comorbid conditions 
or whose BMI is > 40 kg/m2.  Dietary services and exercise physiology referrals outside the 
facility are not a routine, covered TRICARE benefit. 
Team selection and formation.  The committee is comprised of a Committee Chair, an 
expert committee member on the topic, and an outside neutral committee member from the 
University of Nevada Las Vegas (UNLV).  Consultation and coordination is accomplished as 
needed with the AF Research Oversight and Compliance Division and the representative of the 
MTF’s Clinical Research Office and Health Insurance Portability and Accountability Act 
(HIPAA) to assist in processing the project’s approval at the MTF level.  Assistance from 
Information Systems, Population Health/Disease Management, Family Practice Clinic 
leadership, and nutritional and behavioral medicine representatives is available as needed.   
Cost – benefit analysis.  This research utilization project will be part of a larger long-
term project to generate a reduction in obesity rates.  Future interventions will be evaluated if 
findings from this project indicate a gap in the implementation of evidence-based guidelines for the 
identification and treatment of adult obesity.  Considerations for future cost-benefit analyses 
include reduction in therapies for individuals diagnosed with comorbid diseases associated with 
obesity.  Additionally, reduced number of prescriptions required to manage chronic disease, a 
reduction in specialty services, or reducing person-hours required to manage chronic disease in the 
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MTF may be considered.  No cost-analysis will be conducted for this research utilization project 
due to the purpose and length of the project. 
Scope of the project.  The scope of this project is to determine if there is an 
implementation gap between documented identification and treatment and recommended 
identification and treatment of obesity according to the evidence-based VA/DoD obesity screening 
and management guideline. 
Mission/Goals/Objectives 
Mission.  The mission of this research utilization project is to reduce the paucity of 
literature related to adult obesity identification and treatment in the military population and to 
identify if a gap exists between actual and recommended identification and treatment of adult 
obesity in accordance with the VA/DoD evidence-based screening and management guideline. 
Goals.  One goal for this research utilization project is to evaluate if military PCPs 
identify and treat obesity in adults in the primary care setting according to the VA/DoD adult 
obesity guideline.  Additionally, it is anticipated this project will help to reduce gaps in the 
literature related to military PCPs and the identification and treatment of adult obesity in 
accordance with the VA/DoD adult obesity guideline. 
Objectives.  To meet the goal of this project, a retrospective chart audit was conducted to 
establish a baseline for military PCPs’ identification and treatment of obesity in adults in the 
primary care setting according to the VA/DoD adult obesity guideline.  The chart audit began 
after project approval was granted by the UNLV Biomedical Sciences Institutional Review 
Board (IRB) and the AF Research Oversight and Compliance Division approval.  See Appendix 
E for research utilization project timelines and Appendix F for approval letters.  
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Chapter 3 
Theoretical Underpinnings 
Introduction 
 One approach to solving clinical problems is the use of evidence-based practice (EBP), 
which incorporates the best research evidence available with integration of clinical expertise and 
individual preference (Ahmed, Andrist, Davis, & Fuller, 2013; Polit & Beck, 2017).  Sources 
that yield the best evidence are meta-analyses, systematic reviews, and clinical guidelines based 
on randomized controlled research (Zaccagnini & White, 2014).  Other sources of evidence 
come from well-designed quasi-experimental and descriptive research (Dearholt & Dang, 2012).  
Where EBP is used to “inform clinical, administrative, and educational” practice (Dearholt & 
Dang, 2012, p. 4), research utilization allows research study findings to be translated or applied 
in response to clinical issues (Ahmed et al., 2013; Polit & Beck, 2017).   
Several models guide translation of research knowledge into practice.  One such model is 
the diffusion of innovations theory, developed by Everett Rogers in 1962 (Rogers, 2003).  This 
theory focuses on the process whereby an innovation is accepted and integrated as a part of or as 
a whole of the original research.  It also allows adaptation when implementing evidence to 
address local needs and resources (Polit & Beck, 2017).  Rogers’ theory describes the process by 
which an innovation becomes the fabric of a social system and provides ways to bridge gaps 
between research and utilization (Dingfelder & Mandell, 2011). 
Diffusion of Innovations Theory 
There are four major elements described in the diffusion of innovations theory:  (a) 
innovation; (b) communication channel; (c) time; and (d) the social system (Rogers, 2003).  The 
innovation can be a product, practice, program, policy, or service introduced to individuals or 
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groups.  It is not a prerequisite for the innovation to be new; rather, the innovation should 
improve quality for those who adopt the innovation (Leggott et al., 2016).  The innovation must 
demonstrate advantage(s) over other options, be compatible with the values of the users, be 
trialed and easy to use, and have adequate visibility of its success to smooth the path to adoption 
(Rosen & Goodson, 2014).  Communication is the second element of the theory, which occurs 
when individuals or groups receive information about the innovation (Rogers, 2003).  An 
important principle of this element is that individuals or groups have access to this information 
and that the communication is two-way (Kim, Quinn, Chandrasekar, Patel, & Lam, 2016). 
 The third element is time, which considers the length of exposure required for individuals 
or groups to adopt or reject the innovation.  Rogers (2003) enumerates the steps in the 
innovation-decision process to adopt an innovation as:  (a) knowledge; (b) persuasion; (c) 
decision; (d) implementation; and (e) confirmation.  The speed by which the innovation is 
adopted depends on attributes of the adopter.  Innovators are the first adopters who embrace the 
innovation.  Early adopters accept the innovation sooner than the early majority, while the later 
majority tends to be slower in innovation adoption.  The laggards are the skeptics or critics of the 
innovation (Rogers, 2003). 
 The fourth element of the diffusion of innovations theory is the social system.  Within the 
system are leaders that influence the adoption process.  Opinion leaders help diffuse innovations 
among individuals or groups through active and passive communication methods (Nejad, 
Sherrell, & Babakus, 2014).  Change agents garner support from opinion leaders to influence 
adoption of the innovation.  Innovation champions are charismatic and can overcome barriers to 
boost innovation adoption (Rogers, 2003). 
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Application of Diffusion of Innovations Theory 
Many studies have examined various aspects of the four elements within the diffusion of 
innovations theory.  Some studies serve to explore or explain attributes of the innovation, 
communication methods, and rates of adoption.  Other studies help to describe characteristics of 
adopters, opinion leaders, change agents, or champions who influence the social system to better 
explain how the process of diffusion and adoption of an innovation occurs.  Collectively, these 
studies help to understand the dynamic process by which an innovation is translated into 
practice. 
The current project examines the implementation gap between use of the VA/DoD 
evidence-based guideline and PCPs’ provision of care for adult obese individuals.  The VA/DoD 
Figure 1.  Diffusion of Innovations Theory (adapted from Rogers, 2003). 
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guideline has been in existence since 2006, with the most recent update in 2014 (VA/DoD, 2014).  
However, the literature suggests PCPs may not adhere to the established guideline.  One factor that 
influences adoption of the innovation is the concept of observability.  One study using the diffusion 
of innovations theory explored the adoption of EBP by nursing students in an international setting.  
The researchers addressed components of the first element of the theory including advantage, 
compatibility, complexity, trialability, and observability as they relate to adoption of the EBP 
innovation.  Components of Element 1 directly affect persuasion and adoption of EBP.  
Additionally, knowledge of EBP was significantly related to adoption and implementation of the 
innovation (Pashaeypoor, Ashktorab, Rassouli, & Alavi-Majd, 2016).   
Although knowledge can impact adoption and implementation, a study by Nichol et al. 
(2011) reinforced that knowledge alone is not the catalyst for change, but rather exposure to 
ongoing communication within social systems is required to keep the innovation viable.  Following 
initiation of a glucose screening protocol, target glucose screenings for individuals with a 
psychiatric diagnosis increased from 46% to 67% but remained below the targeted 70% threshold.  
When the researchers increased reinforcement tools to include reminder notifications and 
information published in a monthly newsletter, as well as provided reported screening rates to 
individual providers during the second and third year, screenings increased to the 90% threshold.  
Clinics that did not receive reinforcement tools averaged 26% to 38% lower on glucose screenings. 
This theory has been used in the fields of business and technology, as well.  The need to 
understand the adoption and implementation of the Radio Frequency Identification (RFID) 
technology was critical before marketing it to the public.  A questionnaire tested concepts of the 
adoption phase of the theory.  The adoption steps of knowledge, design, decision, and 
implementation were positively associated with adoption of RFID technology.  Interestingly, 
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persuasion had a negative influence.  This demonstrates that uncertainty in adopting newer 
technology can occur when the element of communication to convey innovation benefits is 
suboptimal (Bhattacharya, 2015). 
Leggott et al. (2016) used a mixed methods study to investigate the rate of diffusion of 
innovation when adopting a new anesthetic procedure for surgery.  Adopters in this study 
perceived the new innovation to be safer, more efficient, and easier to use than the older 
anesthetic technique.  Because adopters felt this innovation was better than the previous 
procedure, the year this technique became available there was more than a 15% adoption rate 
that rose to 70% almost a decade later.  Results of this study have been validated by other 
research.  When an innovation is perceived to be credible and adopters are trusting of its use, it is 
much more likely to be implemented (Kim et al., 2016). 
Characteristics of adopters, opinion leaders, change agents, and champions affect 
diffusion of an innovation.  In a survey of 88 nurses, Andrews, Tonkin, Lancastle, and Kirk 
(2013) identified 18 adopter characteristics.  Although not generalizable, some of the 
characteristics noted are possessing greater knowledge and confidence to adopt the innovation 
into practice.  Level of competence and accessibility to the opinion leaders are critical for others 
to adopt an innovation (Rosen & Goodson, 2014).  Equally important is to identify positive as 
well as negative influences that opinion leaders, change agents, and champions have about the 
diffusion process (Nejad et al., 2014).  Diffusion of innovations theory supports the need to 
continue identifying and addressing variables that impact the diffusion process in order to 
successfully implement and sustain an innovation (Dingfelder & Mandell, 2011). 
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Theoretical Constructs 
 The theoretical constructs of the diffusion of innovations theory for this project will be as 
follows.  The innovation is operationalized as the VA/DoD obesity guideline.  To determine if 
PCPs are implementing the VA/DoD guideline, evaluation of the decision, implementation, and 
confirmation to adopt the innovation will be operationalized as the identification of obesity, 
defined as a BMI > 30 kg/m2, as well as use of treatment indicators.  The treatment indicators are 
operationalized as offering diet, exercise, behavioral modification, and pharmacological 
treatment for individuals with a BMI > 30 kg/m2 and bariatric surgical intervention for 
individuals with a BMI > 35 kg/m2 with comorbid conditions or a BMI > 40 kg/m2.  
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Chapter 4 
Project Plan 
Setting 
 This research utilization project was conducted at an AF MTF located in Maryland and 
accomplished with retrospective chart review of EMRs.  The documented treatment of adults 
with obesity was compared to evidence-based treatment guidelines adopted by the VA/DoD for 
screening and management of obesity (VA/DoD, 2014).  The population of interest was adults 
who receive care under the military health insurance known as TRICARE.  Inclusion criteria for 
this evaluation project were EMRs of adults, defined as age 19 years and older with a BMI > 30 
kg/m2, the entry BMI for a diagnosis of obesity. 
Protection of Human Subjects 
Approval from the UNLV IRB was granted on 5 September 2016.  A HIPAA waiver for 
the retrospective review was requested and granted by the UNLV IRB on 24 October 2016.  
Permission to access electronic health records, including the Armed Forces Health Longitudinal 
Technology Application (AHLTA), Composite Health Care System (CHCS), and the CarePoint 
database, was subsequently approved by the AF Research Oversight and Compliance Division 
and the MTF’s HIPAA representative on 23 December 2016.   
Per the AF Research Oversight and Compliance Division, collection of data could only 
occur on records prior to the UNLV IRB approval date of 5 September 2016.  Therefore, 
retrospective review was on records between 1 April to 31 August 2016.  Data collection began 
after 1 January 2017.  To ensure protection of any personally identifiable information, data was 
de-identified, stored securely under password protection, and available only to the primary and 
co-investigators. 
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Data Sources, Sampling, and Data Collection 
A retrospective examination of the MTF’s EMRs was conducted using AHLTA, CHCS, 
and the CarePoint databases to identify adults defined as age 19 and older with obesity, defined 
as a BMI of > 30 kg/m2, who are under the care of a PCP in the MTF’s Family Practice Clinic.  
Review of EMRs continued until 50 records had been identified that met inclusion criteria for 
this project.  Use of the Obesity Treatment Audit Form (see Appendix G), based on the VA/DoD 
obesity guideline, was used to examine the MTF’s EMRs to determine if treatment of obese 
adults proceeded according to the evidence-based guideline recommendations.  The Obesity 
Treatment Audit Form did not contain any private or personal information that could link the 
data collected on individuals or PCPs.   
Each record audited was assigned a number (i.e., Record 1, Record 2, Record 3, etc.) to 
ensure all information was de-identified when written on the Obesity Treatment Audit Form.  
The record number on the audit form was not linked to the EMR.  To provide additional 
protection of confidentiality, electronic data collected is password protected and secured in a 
locked facility at the MTF during data collection.  Following completion of MTF data collection, 
data will then be stored in a locked facility at UNLV for two years post completion of this 
project.  After the designated storage time, the electronic information gathered will be 
electronically deleted and hard copy information will be shredded and recycled. 
Measures 
Seven treatment indicators on the Obesity Treatment Audit Form were collected:  (a) 
diagnosis of obesity if BMI > 30 kg/m2 ; (b) diet/nutritional counsel/consult offered; (c) exercise 
counseling offered; (d) one-month follow-up appointment; (e) behavioral modification 
counsel/consult offered; (f) pharmacologic intervention discussed for all eligible individuals with 
27 
 
a BMI > 30 kg/m2, and (g) bariatric surgery option discussed for individuals with a BMI > 35 
kg/m2 with comorbid conditions or a BMI > 40 kg/m2.   
First, a yes or no was annotated for each indicator to evaluate actual treatment of obesity 
according to the VA/DoD obesity guideline.  These indicators were then tallied and a percentage 
was scored as a calculation of the actual treatments received over total potential recommended 
treatments, known as the Obesity Treatment Composite Score.  This provided comparison 
between actual treatment and treatment according to the guideline recommendations.  For 
instance, if an individual met four of the five potential indicators, the percentage would be 
recorded as 0.80.  If an individual met four out of seven potential indicators, the percentage 
would be recorded as 0.57.  Other variables such as age, gender, and beneficiary category were 
recorded in the IBM® Statistical Package for the Social Sciences, Version 24 (SPSS® 24) 
database, (IBM®, 2016). 
Statistical Analyses 
Analyses of the Obesity Treatment Audit Forms were conducted using SPSS® 24.  
Descriptive data of age, gender, BMI, and beneficiary category were used.  To identify if a gap 
existed between actual treatment of obese adults and treatment according to VA/DoD guideline 
recommendations, frequencies were run for each indicator, as well as a scored percentage of the 
actual versus recommended indicators accomplished.  A composite score could range from 0, 
indicating absence of guideline adherence, to 1.0, indicating full guideline adherence.   
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Chapter 5 
Summary 
Implementation 
 Data collection took place over two days and was accomplished by the co-investigator.  
Records were selected from 1 April to 31 August 2016.  Using the EMR known as AHLTA, 
records were queried, sorting by the Family Practice PCP’s name and the inclusive dates to be 
reviewed.  Records were selected randomly; however, to avoid all data being collected from one 
month, 10 records were selected throughout each of the five-month data collection timeframe.  
Records were selected from the pool of all PCPs available during the data collection period to 
avoid evaluating records from only one or two PCPs in the Family Practice Clinic.  In order to 
ensure records evaluated met eligibility criteria, records were selected on individuals 19 years of 
age or older.  The BMI was only identified once the record was opened to review the note.  
Therefore, a total of 119 records were reviewed in order to obtain 50 records meeting BMI 
criteria of 30 kg/m2 or greater.  Information was gathered using the Obesity Treatment Audit 
Form.  Additional variables of age, gender, beneficiary category, PCP credential type (i.e., 
physician, PA/NP), and reason for visit were collected and entered in a SPSS® 24 database for 
data analysis. 
Results 
 Individual visits.  Of the 50 records studied, 54% (n=27) were male and 46% (n=23) 
were female.  Age of individuals ranged from 21 to 68 years, with an average age of 50 years.  
Twenty percent were active duty (n=10), 8% active duty dependent (n=4), 40% retiree (n=20), 
and 30% retiree dependent (n=15).  There was one individual whose beneficiary category was 
deceased family member and was categorized as other.  
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BMI.  Obesity is defined as Grade I (BMI >30 – 34.9 kg/m2), Grade II (BMI >35 – 39.9 
kg/m2), and Grade III (BMI >40 kg/m2).  The average BMI for the records reviewed was 33.08 
kg/m2, with a range of 30.18 to 55.65.  Sixty-four percent of individuals’ BMI fell between 30 
and 34.9 kg/m2 (n=32), 20% between 35 and 39.9 mg/m2 (n=10), and 16% at 40 mg/m2 and 
above (n=8).  Distribution of BMI by gender, age, and beneficiary category are noted in Table 1. 
Table 1 
Individual Visit Variables 
  
 
Age 
 
 
Beneficiary Category 
Grade I 
BMI 30-
34.99 kg/m2 
Grade II 
BMI 35-
39.99 kg/m2 
Grade III 
BMI 40 
kg/m2 and 
above 
Gender      
  Male      20-29 AD (2) 2 0 0 
      30-39 AD (4) 3 1 0 
      40-49 AD (2) 
Retiree (6) 
2 
5 
0 
1 
0 
0 
      50-59 AD (1) 
Retiree (8) 
1 
5 
0 
2 
0 
1 
      60+ Retiree (4) 1 1 2 
  Female      20-29 AD Dependent (1) 1 0 0 
      30-39 AD Dependent (1) 0 0 1 
      40-49 AD Dependent (2) 
Retiree Dependent (3) 
1 
2 
0 
1 
1 
0 
      50-59 AD Dependent (1) 
Retiree (1) 
Retiree Dependent (8) 
0 
1 
4 
1 
0 
2 
0 
0 
2 
      60+ Retiree (1) 
Retiree Dependent (4) 
Other (1) 
1 
2 
0 
0 
0 
1 
0 
2 
0 
Total  50 31 10 9 
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PCPs.  A total of 119 records were reviewed between 1 April to 31 August 2016 at an 
AF MTF located in Maryland until 50 records were identified that met project eligibility criteria.  
At the time of data collection, there were a total of seven family physicians, six PAs, and one 
NP.  Of the data collected from the resultant 50 records, 52% (n=26) of patients were cared for 
by family physicians and 48% (n=24) were cared for by PAs and NPs.  Individuals were seen for 
annual or wellness visits 20% of the time (n=10), acute issues 56% of the time (n=28), and for 
chronic issues 24% of the time (n=12).  Of note, family physicians cared for more chronic issues 
while PA/NPs cared for more physical or wellness exams (Table 2).  The frequency of 
identification and diagnosis by provider type was similar for both family physician and PA/NPs 
(Table 3). 
Table 2 
Provider Type and Reason for Individual Visit 
 Reason for Visit  
Provider Type Physical Acute Issue Chronic Issue Total 
    Family Physician 3 14 9 26 
    PA/NPs 7 14 3 24 
Total 10 28 12 50 
 
Table 3 
Provider Type and Obesity Identification/Diagnosis 
 Obesity Identification/Diagnosis 
 
 
Provider Type Yes No Total 
    Family Physician 8 18 26 
    PA/NPs 10 14 24 
Total 18 32 50 
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Obesity Treatment Composite Score.  The PCPs diagnosed obesity for 36% of visits 
(n=18).  Of the 18 individuals identified and diagnosed with obesity, 100% received both dietary 
and exercise counsel, 44% (n=8) received or were offered behavioral counseling, and 33% (n=6) 
received a one-month follow-up appointment.  When considering the entire sample, only 36% of 
individuals were offered diet and exercise counsel, 16% were offered behavioral counsel, and 
12% were offered or received a one-month follow-up appointment.  The majority of the follow-
up appointments were with the Disease Manager, as these individuals were identified with 
comorbid conditions such as diabetes or hypertension; however, one individual had a stand-alone 
diagnosis of morbid obesity when seen for follow-up evaluation.   
Of the 50 records reviewed, only 40 individuals were eligible for pharmacologic 
management due to AF guidance on use of medication therapy in the AD population.
 
Figure 2.  Obesity Treatment Indicator Results indicate individuals received obesity treatment 
according to the VA/DoD guideline less than 50% of the time.  
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Of those 40 individuals, there was no recommendation for pharmacologic management.  Based 
on TRICARE eligibility requirements for surgical management, 14 individuals were eligible to 
receive this recommended option.  No eligible individuals were provided this recommended 
option for obesity management.  It should be noted that one individual had received bariatric 
surgery and was categorized as not applicable.  Another individual had received a bariatric 
surgery consult more than two years prior, but this was not readdressed at the visit and was 
categorized as not being offered surgical intervention.  See Figure 2 depicting the obesity 
treatment indicator results.  
 
Figure 3.  PCPs Obesity Treatment Composite Score indicates the majority of individuals 
received one indicator or less for their obesity identification and treatment. 
 
The Obesity Treatment Composite Score averaged 0.22, ranging from 0.00 to 1.00.  
When categories were grouped, 56% (n=28) scored 0.00, 8% (n=4) ranged from 0.01 to 0.24, 
10% (n=3) ranged from 0.25 to 0.49, 24% (n=12) ranged from 0.50 to 0.74, 2% (n=2) ranged 
from 0.75 to 0.99, and 2% (n=1) met 100% of the interventions recommended by the VA/DoD 
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guideline (see Figure 3 for PCP Obesity Treatment Composite Score results).  The average 
composite score was 0.22 and 0.23 for physicians and PA/NPs respectively. 
Discussion 
 The purpose of this research utilization project was to determine if military PCPs are 
identifying and treating obesity in adults in the primary care setting according to the VA/DoD 
adult obesity guideline.  Obesity has been associated with several cardiovascular, metabolic, and 
functional issues such as T2DM, dyslipidemia, osteoarthritis, and depression (Bray, Look, & 
Ryan, 2013; Rueda-Clausen et al., 2015).  In the military population, obesity affects recruitment 
and the readiness mission (Stefan, 2016).  In one cohort study of military members who were 
followed for a period of 36 years beginning at age 22, it was found that males with early 
adulthood obesity were at increased risk for developing ischemic heart disease and congestive 
heart failure (Schmidt, Bøtker, Pedersen, & Sørensen, 2014).  However, effects of obesity can be 
mitigated with a small amount of weight loss, accomplished with just a brief mention of obesity 
and treatment advice at a primary care visit (Aveyard et al., 2016). 
Identification/Diagnosis of Obesity.  Primary care providers are well-positioned to 
discuss weight management with patients, because they are the individual’s first-line assessment 
(Asselin, Osunlana, Ogunleye, Sharma, & Campbell-Scherer, 2015).  Yet findings from this 
research utilization project indicate PCPs identify and diagnose obesity only 36% of the time.  
This result is better than or comparable to other studies demonstrating rates ranging from 23.8% 
to 42% (Farran, Ellis, & Barron, 2013; Fitzpatrick & Stevens, 2017; Klabunde et al., 2014; 
Petrin, Kahan, Turner, Gallagher, & Dietz, 2016).  Records evaluated from one study required 
hand calculation of the BMI.  Interestingly, of those that met obesity criteria, less than 1% were 
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identified and diagnosed; however, 12 records included an obesity diagnosis but had no recorded 
BMI (Barnes, Theeke, & Mallow, 2015).   
It was not determined in this research utilization project whether PCPs understood the 
definition of obesity, but in a study by Meadows and Weiss (2015), 86% of the providers were 
able to correctly define overweight and obesity.  An interesting finding, though, was that only 
37% of the nonprovider staff were able to correctly define overweight and obesity.  In a military 
Family Practice Clinic setting, increased reliance on medical support staff is made when taking 
an accurate medical history.  When medical support staff bring clinical problems to the attention 
of the PCP, there is greater opportunity for an issue such as obesity to be addressed when both 
parties are knowledgeable. 
Diet, Exercise, and Behavioral Counsel.  For individuals in this research utilization 
project whose obesity was identified and diagnosed during a visit, 100% of them were provided 
diet and exercise counsel.  However, of the total obese individuals studied, only 36% were 
offered information on diet and exercise, and 16% were offered behavioral counseling.  This 
suggests diet, exercise, and behavior modification counsel were only offered if the diagnosis of 
obesity was made, and not as a routine part of healthy lifestyle advice.  No records noted advice 
given for commercial weight loss programs or meal replacement regimens (Tsai et al., 2016).  
This could be a reflection that TRICARE does not provide coverage for such programs. 
Findings from this research utilization project were similar to a study conducted by 
Magee, Everts, and Jamison (2012).  The authors found PCP advice on weight loss interventions 
occurred 34.4% of the time, but the study did not specify which interventions were offered 
(Magee et al., 2012).  Farran et al. (2013) reported a much lower intervention rate for diet, 
exercise, and behavior modification counsel at 8.6%, 4.8%, and 1% respectively.  Although 
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Magee et al. (2012) found a significant difference between interventions offered by physicians 
and NPs (x2[1, n=180] = 56.69, p < 0.001), little difference in obesity practice between 
physicians (0.22 average composite score) and PA/NPs (0.23 average composite score) were 
noted in this research utilization project. 
Pharmacotherapy.  The VA/DoD obesity guideline (2014) recommends adjunct 
treatment with pharmacotherapeutics for individuals who are obese, those whose BMI is > 27 
kg/m2 with comorbid conditions.  There were no individuals in this research utilization project 
who were offered adjunct medication therapy.  Six of the medications currently approved by the 
Federal Drug Administration are phentermine, orlistat, lorcaserin, naltrexone-bupropion, 
phentermine-topiramate, and liraglutide (Apovian et al., 2015).  A systematic review and meta-
analysis for five of these medications demonstrated at least a 5% weight loss that was sustained 
across nearly an entire year (Khera et al., 2016).  Despite demonstrated efficacy, under 
TRICARE guidelines weight loss medications are not a formulary item (TRICARE, 2016b).  A 
PCP may write a prescription to be filled at a local network pharmacy, but the individual would 
be responsible to cover the cost of the prescription.   
Irrespective of systematic barriers, other strategies can be considered to achieve options 
for pharmacologic treatment (Tsai et al., 2016).  Phentermine is a relatively inexpensive 
medication, and many individuals who have no contraindications may desire this as an adjunct 
therapy.  Orlistat has a preparation that is an over-the-counter product that can be suggested as an 
option for the individual.  A final strategy is for the PCP to place a nonformulary request with 
justification for the medication.  If approved, this could provide the individual with adjunct 
therapy.  Developing regional expertise and educating PCPs can enhance utilization of 
medication therapy (Tsai et al., 2016). 
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Bariatric Surgery.  Bariatric surgery is recommended for individuals who are morbidly 
obese, or individuals whose BMI is > 35 kg/m2 with comorbid obesity conditions and who have 
attempted to lose weight without improvement (VA/DoD, 2014).  It is reported nationally the 
prevalence rate for morbid obesity is 6.4%, yet the rate of bariatric surgery is only 1.5% for those 
qualified to receive this treatment option (Idzik & Davenport, 2011; Petrin et al., 2016).  For this 
research utilization project, there were no PCPs who recommended bariatric surgery as a 
treatment option.  As observed with pharmacologic therapy, one might initially speculate that 
this treatment option is not a covered TRICARE benefit.  However, TRICARE does cover 
bariatric surgery (TRICARE, 2016a) per the VA/DoD guideline recommendations (VA/DoD, 
2014), thus consideration should be made regarding PCP education and attitude toward obesity 
treatment to assist in designing interventions to improve the identification/diagnosis and 
treatment of obesity in military primary care settings (Salinas, Glauser, Williamson, Rao, & 
Abdolrasulnia, 2011). 
Implications/Sustainability/Need for Future Evidence-Based Projects 
 Use of an obesity guideline assists PCPs in the identification and effective treatment of 
obesity in the primary care setting (Kushner & Ryan, 2014).  In this project, identification and 
treatment of obesity occurred 22% of the time.  This reflects that translating the guideline into 
clinical practice is challenging.  The Diffusion of Innovations Theory addresses four elements by 
which the VA/DoD obesity guideline could be diffused into the military social system, including 
aspects of the innovation itself, communication, adoption process, and influence of the social 
system.    
Areas that may have limited the use of the VA/DoD obesity guideline are lack of 
familiarity or provider agreement, patient receptivity and stigma, patient compliance with 
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change, and system or organizational constraints can influence use of guidelines (Abruzzino & 
Marra, 2015; Gunther, Guo, Sinfield, Rogers, & Baker, 2012; Idzik & Davenport, 2011; Monsen 
et al., 2014; Sadeghi-Bazargani et al., 2014; Sinfield et al., 2013).   
A PCPs decision to accept or reject use of the guideline is dependent on their knowledge 
and attitude toward the guideline.  Studies show education and peer reviews alone may produce 
variable outcomes in adherence to use of a guideline (Idzik & Davenport, 2011; Monsen et al., 
2014).  However, education and training, in conjunction with tools such as outreach, reminders, 
and sustained support, be implemented to improve providers’ adherence to guidelines (Farran et 
al., 2013; Idzik & Davenport, 2011; Monsen et al., 2014).  Additionally, a PCP's skill influence 
the offering of weight loss advice to patients (Dutton et al., 2014; Farran et al., 2013).  Brief 
training on motivational interviewing and use of the 5As approach can offer PCPs additional 
tools that build skill and confidence to counsel obese patients on guideline recommendations 
(Edwards, Stapleton, Williams, & Ball, 2015; Gudzune, Clark, Appel, & Bennett, 2012; Vallis et 
al., 2013).   
Finally, guidelines that are easy to follow with limited organizational constraints can 
enhance utilization (Gunther et al., 2012; Klabunde et al., 2014).  Implementation of enhanced 
collaborative and consultative mechanisms can increase the provider’s confidence to refer 
individuals for additional care and shifts sole responsibility from the PCP to a coordinated 
organizational response (Gunther et al., 2012; Monsen et al., 2014).   
Further evaluation needs to be conducted to identify the barriers unique to this MTF.  
Without understanding the barriers, it can make targeting effective interventions difficult.  By 
focusing future evidence-based projects on these areas, it may enhance the diffusion of the 
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obesity guideline into practice and ultimately reduce the consequences of obesity for this 
population. 
Limitations 
 This research utilization project has several identified limitations.  The small number of 
records audited may limit providing an accurate clinical picture of obesity management.  It could 
be possible that the identification/diagnosis and treatment of adult individuals in this sample setting 
was actually higher or lower than reported.  The need for sampling a larger number of records is 
indicated.  Additionally, there are approximately 75 MTFs in the AF Medical Service.  Findings 
from this population may not be reflective of practices at other DoD medical facilities.  However, 
the data collected, although random, were somewhat systematic to ensure audits were conducted 
throughout each month of the data collection period, as well as to ensure each PCP was audited 
equally to avoid targeting only one or two.  Further, more explicit details of the intervention were 
not addressed in this research utilization project.  If dietary counsel was documented, this was 
counted as an intervention.  However, it was not specific to whether the PCP offered calorie 
information, use of food logs, use of commercial products, or other dietary counsel.  It is possible 
one dietary intervention may offer greater benefit than another.  
A historical bias that may have influenced project outcomes is that this particular MTF site 
is one of the locations staffed with a research division that spawned research related to diabetes and 
obesity under the Diabetes and Obesity Research Working Group established in 2010 (True, 
Cranston, & Hatzfeld, 2013).  It is possible project outcomes may have been influenced by some of 
the working group’s activities. 
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Dissemination of Future Scholarly Activity and Results 
Following defense of this research utilization project, it is anticipated that the findings 
will be formally presented to the MTF’s executive leadership as well as to the Population Health 
Working Group.  Locally, results will be forwarded to the MTF’s EBP and Quality Councils.  
Future evidence-based interventions are being planned to improve PCPs’ adherence to guidelines 
for the identification and treatment of obesity.  Following additional planned interventions, the 
principal investigator (PI) anticipates seeking publication of the findings in the peer-reviewed 
journal, Military Medicine.  If program interventions are successful, this author plans to 
collaborate with the Diabetes and Obesity Research Working Group to advance policy at AF and 
possibly DoD levels to improve obesity rates for TRICARE beneficiaries.  Finally, this author 
plans to request for either podium or poster presentation at the American Association of Nurse 
Practitioners National Conference in 2018 and other appropriate professional presentation 
opportunities that impact cardiometabolic health. 
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Appendix A 
Obesity Assessment Tools:  Advantages and Disadvantages 
Assessment Tool Advantage Disadvantage 
BMI Easy, inexpensive; estimates 
abdominal subcutaneous fat 
Lean body mass can lead to 
elevated measurement; does not 
account for non-European stature; 
less predictive for central obesity 
WC Easy, inexpensive; predictive of 
central obesity; race specific 
Reduced reproducibility 
WHR Predictive of central obesity Reduced reproducibility 
WSR Easy, inexpensive; good for non-
obese; race specific 
Reduced reproducibility 
Skinfold 
thickness 
Inexpensive Timely; requires training; 
variability; reliability low in 
severely obese; not reliable for 
central obesity 
MRI Accurate   Expensive; time consuming 
CT Accurate Expensive; exposure to radiation; 
time consuming 
Ultrasound Accurate to measure 
subcutaneous fat 
Expensive; less accurate with skin 
compression and fat plasticity 
DEXA Accurate; safe except in 
pregnancy; can assess central 
obesity 
Expensive; time consuming 
Air Densitometry Accurate; no water immersion Expensive; cannot determine body 
composition 
Hydrodensitometry Very accurate Expensive; time consuming; must 
be underwater to measure; poor 
determinant of body composition 
Bioelectrical 
Impedance 
Fast, easy Not accurate; dependent on 
hydration status; equipment cost 
Sources:  Adapted from Müller et al., 2013; Rueda-Clausen et al., 2015 
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Appendix B 
AGREE II Appraisal of Obesity Guidelines 
  Endocrine 
Society VA/DoD
AHA/ACC/ 
TOS USPTF
1. The overall objective(s) of the guideline is (are) specifically 
described. 6 7 7 5
2. The health question(s) covered by the guideline is (are specifically 
described). 1 7 7 7
3. The population (patients, public, etc.) to whom the guideline is 
meant to apply is specifically described. 5 6 6 6
Total (21) 12 20 20 18
4. The guideline development group includes individuals from all 
the relevant professional groups. 4 6 6 4
5. The views and preferences of the target population (patients, 
public, etc.) have been sought. 2 2 2 2
6. The target users of the guideline are clearly defined. 7 7 7 7
Total (21) 13 15 15 18
7. Systematic methods were used to search for evidence. 7 7 7 7
8. The criteria for selecting the evidence are clearly described. 6 7 7 6
9. The strengths and limitations of the body of evidence are clearly 
described. 6 6 6 6
10. The methods for formulating the recommendations are clearly 
described. 5 6 6 5
11. The health benefits, side effects and risks have been considered 
in formulating the recommendations. 6 6 6 6
12. There is an explicit link between the recommendations and the 
supporting evidence. 5 6 6 5
13. The guideline has been externally reviewed by experts prior to 
its publication. 5 5 7 6
14. A procedure for updating the guideline is provided. 4 7 6 6
Total (56) 44 50 51 47
15. The recommendations are specific and unambiguous. 6 6 6 5
16. The different options for management of the condition or health 
issue are clearly presented. 6 7 7 5
17. Key recommendations are easily identifiable. 7 7 7 5
Total (21) 19 20 20 15
18. The guideline describes facilitators and barriers to its 
application. 3 4 3 6
19. The guideline provides advice and/or tools on how the 
recommendations can be put into practice. 4 4 4 6
20. The potential resource implications of applying the 
recommendations have been considered. 1 1 1 1
21. The guideline presents monitoring and/or auditing criteria. 4 4 4 4
Total (28) 12 13 12 17
22. The views of the funding body have not influenced the content of 
the guideline. 7 3 7 7
23. Competing interests of guideline development group members 
have been recorded and addressed. 7 1 7 1
Total (14) 14 4 14 8
95 102 112 108
1. Rate the overall quality of this guidance. 4 5 6 5
2. I would recommend this guideline for use (please respond: yes, 
yes with modifications, or no). Y  Y w/mod Y w/mod Y w/mod
Total Composite Score (161)
Overall 
Guideline 
Assessment
Clarity of 
Presentation
Applicability
Editorial 
Independence
Rigor of 
Development
Domain Item
AGREE II Rating
Stakeholder 
Involvement
Scope and 
Purpose
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Appendix C 
Obesity Guideline Recommendations 
Recommendation 
Endocrine 
Society VA/DoD 
AHA/ACC/ 
TOS USPTF 
Clinic Assessment Not applicable BMI BMI, WC BMI 
Diet 
Counsel BMI 
>25 
Counsel all 
Varietyb 
CLIf as 
indicated x 6 
month 
CLI for 
BMI >25 
Exercise 
Counsel BMI 
>25 
Counsel all 
Varietyc 
High-intensity 
>14 sessions x 6 
month 
CLI for BMI 
>25 
Behavioral 
Counsel 
Counsel BMI 
>25 MId 
May use 
commercial 
product 
CLI for BMI 
>25 
Pharmacologic 
Options 
Meds at BMI 
>27 wca, >30 
Meds at BMI 
>27 wca, >30 
Not available at 
time of 
publication 
Balance 
risk/benefit 
Surgical Options 
BMI >35 wca, 
>40 
BMI >35 wca, 
>40 BMI >40 Not reviewed 
Follow-up 
Every 1 month, 
then every 3 
months, stop if 
no change 
Annual; CLIe 
every month 
for 12 months 
Face-to-face or 
telephone 
support 
No evidence to 
support 
frequency of 
screening; CLI 
12-26 
sessions/yr 
Shared decision-
making Yes Yes Not discussed Not discussed 
 
Sources:  Apovian et al., 2015; Jensen et al., 2013; Moyer, 2012; VA/DoD, 2014. 
 
awc = with comorbidity (i.e. T2DM, HTN, dyslipidemia, OSA); blow carb, low fat, DASH 
diet, low calorie, meal replacement; c10 minute short burst to longer continuous; dMI = 
motivational interview; eComprehensive Lifestyle (diet, exercise, behavioral counsel) 
Intervention w/moderate activity 150-300 minutes/week; fCLI w/high-intensity activity 
200-300 minutes/week, include smoking cessation counsel 
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Appendix D 
Pharmacologic Agents for Treatment of Obesity 
Medication Activity Recommended Dose Benefits Risks 
Orlistat OTCa Lipase inhibitor 60 mg 3 times daily Weight loss 2-3% 
Decrease in LDL-Cb 
Good safety profile 
Non-systemic 
Inexpensive 
Gastrointestinal (GI) 
upset: Oily stools, 
bowel urgency 
 
Orlistat 
(prescription) 
Lipase inhibitor 120 mg 3 times 
daily 
See above 
 
See above 
More expensive than 
Orlistat OTC 
Phentermine Sympathomimetic 
agent 
15 mg daily, 
increase as indicated 
30 mg daily 
37.5 mg (resin)  
75 mg daily max 
Inexpensive 
Weight loss 3-5% 
Elevated heart 
rate/palpitations/ 
blood pressure, 
insomnia 
GI upset 
Caution in use with 
CV disease 
Phentermine/ 
topiramatec 
extended 
release 
Sympathomimetic 
agent/carbonic 
anhydrase 
inhibitor 
3.75 mg/23 mg daily 
for 2 weeks, then 
increase as tolerated 
7.5 mg/46 mg daily 
11.25 mg/69 mg 
daily 
15 mg/92 mg daily 
Weight loss >5% Expensive 
Same as 
Phentermine 
Altered taste 
Paresthesia 
Depression/anxiety 
Teratogenic 
Lorcaserinc Serotonin 5HT-2C 
receptor agonist 
10 mg 2 times daily Weight loss 
Improved Hgb A1Cd 
Tolerability good 
Expensive 
May experience 
headache, nausea, 
dry mouth, 
constipation 
Risk of serotonin 
syndrome w/ other 
serotonergic meds 
Naltrexone/ 
Bupropion 
μ-opioid 
antagonist/ 
dopamine & 
noradrenaline 
reuptake inhibitor 
8 mg/90 mg 1 tablet 
for 1-2 weeks, then 
2 tablets for 3-4 
weeks, then 2 tablets 
2 times daily 
Weight loss >5% 
Treatment for food 
addiction 
 
Mid-range cost 
Headache, 
nausea/vomiting, 
dizziness 
Liraglutide Glucagon-like 
peptide-1 agonist 
0.6 mg daily, 
increase to max 3 
mg subcutaneous 
daily 
Weight loss Expensive 
Injection 
Thyroid medullary 
cancer 
Nausea/vomiting 
Pancreatitis 
Sources:  Adapted from Apovian et al., 2015; Chugh & Sharma, 2012; McKinney, 2013; Ryan, 2014. 
 
aOTC = over-the-counter; bLDL-C = low density lipoprotein cholesterol; cDiscontinue if ineffective after 
12 weeks; dHgb A1C = glycated hemoglobin 
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Appendix E 
Detailed Research Utilization Project Timeline 
Task Date(s) Category/Objective Task 
 
4 Jan – 11 Apr 2016 
 
Proposal Defense 
 
Draft Chapter 1 – Introduction 
Draft Chapter 2 – Literature Review 
Draft Chapter 3 – Theoretical Underpinnings 
Draft Chapter 4 – Project Plan 
Committee Approval 
Proposal Defense Presentation 
 
1 Jun - 22 Sep 2016 
 
IRB Approval 
 
Submit IRB application with requested 
modification to UNLV IRB 
 
6 - 30 Sep 2016 Update Chapter Drafts Update Chapter 1 - Introduction 
 
1 - 31 Oct 2016 
 
Update Chapter Drafts Update Chapter 2 – Literature Review 
20 - 24 Oct 2016 IRB/AF Research Oversight 
and Compliance Division 
Approval 
 
Submit UNLV IRB approval letter with 
requested modification to AF Research 
Oversight and Compliance Division 
1 Nov - 30 Nov 2016 Update Chapter Drafts Update Chapter 3 – Theoretical 
Underpinnings 
 
1 Dec - 17 Dec 2016 Update Chapter Drafts Update Chapter 4 – Project Plan 
 
1 Dec - 23 Dec 2016 AF Research Oversight and 
Compliance Division Approval 
Coordinate with MTF Clinical Research 
Office and AF Research Oversight and 
Compliance Division for final approval to 
conduct research utilization project 
 
9 Jan - 29 Jan 2017 Data analysis Analyze demographic and audit data 
 
30 Jan - 3 Apr 2017 Research Project Defense Draft Chapter 5 – Results 
Committee Approval 
Project Defense Presentation 
 
4 Apr - 21 Apr 2017 Research Project 
Dissemination 
Finalize edits 
Prepare presentation for MTF Executive 
Staff 
Prepare research project for dissemination to 
Military Medicine journal 
Initiate expansion of research utilization 
project to improve AF obesity rates 
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Appendix F 
 
University of Nevada – Las Vegas Institutional Review Board and  
AF Research Oversight and Compliance Division Approval Letters 
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Appendix G 
Obesity Treatment Audit Form 
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